It is unclear how the Trump administration will consider affordability when reviewing a drug, as prices are usually ...

Dr. Marty Makary, FDA commissioner, joins 'Squawk Box' to discuss what hindsight tells science about the best route to take post-Covid, changes to the Vaccine Advisory Committee and much more.

FDA Commissioner Marty Makary suggests his agency may expedite drug reviews for manufacturers reducing U.S. prices to global ...